VITRUVIA MEDICAL AG |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4 EUR | 0.00% |
|
-20.00% | -66.67% |
| 2023 | Vitruvia Medical AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| 2022 | Vitruvia Medical AG announced that it expects to receive CHF 2.2 million in funding | CI |
Business Summary
Sales per Business
| EUR in Million | 2020 | Weight | Delta |
|---|---|---|---|
Circular Systems
97.0
%
| 6 | 97.0 % | - |
Other
3.0
%
| 0 | 3.0 % | - |
Sales per region
| EUR in Million | 2020 | Weight | Delta |
|---|---|---|---|
Germany
100.0
%
| 6 | 100.0 % | - |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Claus Wiest
CEO | Chief Executive Officer | - | - |
| Chairman | - | 31/10/17 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 31/10/17 | |
Robert P. Sieber
BRD | Director/Board Member | - | - |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 0 | 2,511,578 | 0 | 0 | nan % |
Company contact information
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| -66.67% | 996K | |
| +5.70% | 32.88B | |
| +18.46% | 7.84B | |
| +22.71% | 3.95B | |
| -17.95% | 3.11B | |
| -19.93% | 1.38B | |
| -30.65% | 1.21B | |
| +4.36% | 933M | |
| -34.81% | 911M | |
| -26.60% | 829M |
- Stock Market
- Equities
- 991 Stock
- Company Vitruvia Medical AG
